UNITED STATES ~~SECURITIES~~ ~~AND EXCHANGE COMMISSION~~

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

~~CURRENT~~Current ~~REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934~~ Report

~~Date~~Pursuant ofto ~~Report~~Section 13 ~~(Date~~or 15(d) of ~~Earliest~~the ~~Event~~Securities ~~Reported):~~Exchange ~~March 31,~~Act ~~2011~~of 1934

Date of Report (Date of Earliest Event Reported): June 17, 2011

MedQuist Inc.

(Exact Name of Registrant as Specified in Charter)

New Jersey		0-19941		22-2531298
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. ~~Employer~~EmployerIdentification ~~Identification~~ No.)

9009 Carothers Parkway ~~Franklin, Tennessee 37067 (Address of Principal Executive Offices) (Zip Code)~~

~~(866) 295-4600 (Registrant’s telephone number~~Franklin, ~~including~~Tennessee ~~area code)~~37067

~~Not Applicable~~ (~~Former~~Address ~~name~~of orPrincipal ~~former~~Executive ~~address,~~Offices) if(Zip ~~changed since last report~~Code)

(866) 295-4600

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~TABLE~~Item OF8.01. Other ~~CONTENTS~~Events.

~~Item~~On 2February 8, 2011 and February 10, 2011, two of MedQuist Inc.05's ~~Costs~~minority ~~Associated~~shareholders filed class action complaints in the Superior Court of New Jersey, Burlington County, Chancery Division, (the “Court”) against us, the individual members on our board of directors and MedQuist Holdings Inc. (the “Shareholder Litigation”). Plaintiffs alleged that the defendants breached certain fiduciary duties they owed to our minority shareholders in connection with ~~Exit~~the orstructuring ~~Disposal~~and ~~Activities~~disclosure of MedQuist Holdings Inc.'s ~~Item~~public 8exchange offer under which it acquired additional shares of our common stock resulting in MedQuist Holdings Inc.01 ~~Other~~owning ~~Events~~approximately ~~SIGNATURES~~97% of our issued and outstanding shares (the “Public Exchange Offer”).

~~Item 2~~On March 4, 2011, the parties to the Shareholder Litigation entered into a memorandum of understanding (the “MOU”) that outlined the material terms of a proposed settlement of the Shareholder Litigation.05 Under ~~Costs~~the ~~Associated~~terms of the MOU, MedQuist Holdings Inc. agreed to extend the expiration of the Public Exchange Offer and further agreed that if, as a result of the Public Exchange Offer, it obtained ownership of at least 90% of our outstanding common stock it would conduct a short-form merger under applicable law to acquire the remaining shares of our common stock that it does not currently own at the same exchange ratio applicable under the Public Exchange Offer. We agreed to make certain supplemental disclosures concerning the Public Exchange Offer, which were contained in an amendment to Schedule 14D-9 that we filed with ~~Exit~~the orSEC ~~Disposal~~on ~~Activities~~March 7, 2011. We also agreed to use our best efforts to finalize a stipulation of settlement (the “Stipulation of Settlement”) and present it to the Court for preliminary approval within thirty days of the date of the MOU.

~~Restructuring~~On ~~Plan~~April ~~Associated~~1, ~~With~~2011, ~~Completion~~the parties executed the Stipulation of Settlement that memorialized the ~~Integration~~terms of ~~Spheris~~the ~~Operations~~settlement outlined in the MOU. On this same date, plaintiffs' counsel filed with the Clerk of the Court a Motion for Preliminary Approval of the Proposed Stipulation of Settlement. The Motion asked the Court to, among other things, (a) hold a hearing to address preliminary approval of the Stipulation of Settlement, (b) certify a class, for purposes of effectuating the Stipulation of Settlement only, of all our shareholders (except the named defendants and their families and affiliates) as of and including the date of the closing of the short-form merger contemplated under the Stipulation of Settlement, and (c) schedule a final hearing within 60 days to determine whether the Stipulation of Settlement is reasonable and fair and should receive final approval.

~~MedQuist~~The ~~Inc.~~Court ~~(the~~held ~~“Company”)~~a ~~announced~~preliminary ~~that~~approval hearing on ~~March 31~~April 19, 2011, ~~its senior management team approved~~ and ~~the~~entered ~~Company~~an ~~implemented~~Order apreliminarily ~~restructuring~~approving ~~plan~~the ~~associated~~settlement ~~with~~and ~~the~~setting ~~completion~~a offinal ~~the~~approval ~~integration of~~hearing ~~the~~for ~~Company’s~~June ~~acquisition~~17, of2011 (the ~~Spheris~~“Preliminary ~~operations.~~Approval Order”). The ~~plan~~Preliminary ~~consists~~Approval ofOrder ~~(i) a~~also ~~reduction~~required ~~in workforce~~us ~~termination~~to ~~costs~~provide ofmail ~~$1.0 million for employee severance~~ and ~~(ii) a~~publication ~~charge~~notice of ~~$1.5 million,~~the ~~which~~proposed ~~represents~~settlement ~~$2.5 million~~to ofall ~~future~~shareholders ~~lease~~of ~~payments~~recorded onand ~~MedQuist~~established ~~Inc.’s~~deadlines ~~former~~for ~~corporate headquarters~~objections into ~~Mount~~the ~~Laurel,~~settlement ~~New Jersey~~ and ~~its~~for ~~former~~filing ~~data~~briefs ~~center~~ in ~~Sterling,~~support ~~Virginia, offset by expected sublease rentals. The reduction of workforce termination costs will consist entirely of severance costs,~~ and ~~the severance costs will result~~ in ~~future~~opposition ~~cash~~to ~~expenditures~~the settlement.

~~Item 8~~On June 17, 2011, following mail and publication notice to our shareholders, the Court held a fairness hearing on the settlement.01 On ~~Other~~this ~~Events~~ date, the Court entered an Order and Final Judgment (the “Final Judgment”) that, among other things, (a) certified the settlement class consisting of all our shareholders (except the named defendants and their families and affiliates) as of and including the date of the closing

Onof ~~March 31,~~the ~~2011,~~short-form inmerger ~~connection~~contemplated ~~with~~under the ~~conclusion~~Stipulation of Settlement (the ~~litigation~~“Settlement ~~matters~~Class”), ~~related~~(b) tofound the ~~Company’s~~ ~~billing~~terms ~~practices,~~set ~~the~~forth ~~Company’s~~in ~~board~~the Stipulation of ~~directors~~Settlement ~~terminated~~to ~~the~~be ~~Company’s~~fair ~~customer accommodation~~and ~~program~~reasonable and ~~reversed~~in ~~accruals~~the best interests of ~~$9.7 million~~the Settlement Class, ~~resulting~~and in(c) aapproved ~~non-cash~~the ~~reduction~~application ~~of expenses~~for ofattorney's ~~approximately~~fees ~~$9.7 million~~and incosts ~~the~~and ~~first~~awarded ~~quarter~~plaintiffs' ofcounsel ~~2011~~$400,000.

A copy of the Final Judgment is attached hereto as Exhibit 99.1 and is incorporated herein by reference into this Item 8.01. The foregoing description is a summary only and does not purport to be complete; it is qualified in its entirety by reference to the Stipulation of Settlement, the MOU, the Motion for Preliminary Approval of the Proposed Stipulation of Settlement, the Final Judgment and plaintiffs' complaints and other applicable court filings.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.



Exhibit No.		Description of Exhibit

99.1		Order and Final Judgment, In Re: MedQuist Inc. Shareholder Litigation, Docket Number C-018-11, dated June 17, 2011.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MedQuist Inc.
Date: April 6, 2011	By:	/s/ Mark R. Sullivan
		Mark R. Sullivan
		General Counsel, Chief Compliance Officer and Secretary



Date: June 23, 2011	MedQuist Inc. By: /s/ Mark R. Sullivan Mark R. Sullivan General Counsel, Chief Compliance Officer and Secretary

Exhibit Index



Exhibit No.		Description of Exhibit

99.1		Order and Final Judgment, In Re: MedQuist Inc. Shareholder Litigation, Docket Number C-018-11, dated June 17, 2011.

Filing Compare · MEDQUIST INC